Manuel Velasco
About
In The Last Decade
Manuel Velasco
101 papers receiving 960 citations
Peers
Comparison fields: 5 of 118
- Cardiology and Cardiovascular Medicine 370
- Endocrinology, Diabetes and Metabolism 236
- Physiology 186
- Molecular Biology 174
- Pharmacology 139
Countries citing papers authored by Manuel Velasco
This map shows the geographic impact of Manuel Velasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Velasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Velasco more than expected).
Fields of papers citing papers by Manuel Velasco
This network shows the impact of papers produced by Manuel Velasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Velasco. The network helps show where Manuel Velasco may publish in the future.
Co-authorship network of co-authors of Manuel Velasco
This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Velasco. A scholar is included among the top collaborators of Manuel Velasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Velasco. Manuel Velasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | 21 | |
| 5 | 11 | |
| 6 | 5 | |
| 7 | 18 | |
| 8 | 10 | |
| 9 | Biologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study | 1 |
| 10 | Hábito tabáquico y enfermedad cardiovascular | 0 |
| 11 | Actividad física y enfermedad cardiovascular | 7 |
| 12 | Ingestion of lean beef meats in blood pressure and biochemical parameters in hypertensives patients | 1 |
| 13 | Niveles inusualmente elevados de Lipoproteína(a) en poblaciones Afro-Americanas del sur del Lago de Maracaibo | 1 |
| 14 | Variables hemodinamicas versus hormonas endoteliales en hipertensos y diabéticos tipo 2 con disfunción endotelial | 0 |
| 15 | Prevalencia de las diferentes alteraciones del perfil lipídico en la consulta de Factores de Riesgo Cardiovascular del Centro de Investigaciones Endocrino-Metabólicas "Dr. Félix Gómez" en el período de Enero del 2006 a Enero de 2007 | 1 |
| 16 | Ciprofibrate diminishes non-hdlc and improves hdlc in patients with frederickson type iv dyslipidemia phenotype | 1 |
| 17 | 7 | |
| 18 | 53 | |
| 19 | Características textuales como medida cualitativa de la información en la generación semiautomática de tesauros | 1 |
| 20 | Combined clonidine and hydralazine therapy in severe and refractory hypertension. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.